Vanda Pharma (NASDAQ:VNDA) reported its Q4 earnings results on Wednesday, February 7, 2024 at 04:02 PM.
Here's what investors need to know about the announcement.
Earnings
Vanda Pharma beat estimated earnings by 55.56%, reporting an EPS of $-0.04 versus an estimate of $-0.09.
Revenue was down $19.21 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 21.94% drop in the share price the next day.
To track all earnings releases for Vanda Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.